Ross W. Paterson - Concepedia

Author

Ross W. Paterson

Also Known As

Janne M. Papma, Paterson, R, Paterson, Ross W., R W Paterson, R. W. Paterson, R. W. W. Paterson, R.W. Paterson, Ross Paterson, Ross W Paterson, Ross W. Paterson

155

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

University College London UK Dementia Research Institute National Hospital for Neurology and Neurosurgery University of Gothenburg London School of Hygiene & Tropical Medicine

About

Ross W. Paterson is an author at University College London specializing in neuroscience, dementia, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	247
2	Health Sciences	3	3	169
3	Arts	2	2	68
4	Social Sciences	2	2	68
5	Cognitive Science	2	2	68

Ross W. Paterson

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings Ross W. Paterson, Rachel Brown, Laura Benjamin, Brain	2020	1.1K
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease Amanda Heslegrave, Wendy Heywood, Ross W. Paterson, Molecular Neurodegeneration	2016	312
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome Stephen Keddie, Julia Pakpoor, Christina Mousele, Brain	2020	311
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes Nadia Magdalinou, Ross W. Paterson, Jonathan M. Schott, Journal of Neurology Neurosurgery & Psychiatry	2015	247
Increased CSF neurogranin concentration is specific to Alzheimer disease Henrietta Wellington, Ross W. Paterson, Erik Portelius, Neurology	2016	245
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay Wendy Heywood, Daniela Galimberti, Emily Bliss, Molecular Neurodegeneration	2015	154
Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta Charles Arber, Jamie Toombs, Christopher Lovejoy, Molecular Psychiatry	2019	151
Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic Ross W. Paterson, Catherine F. Slattery, Teresa Poole, Alzheimer s Research & Therapy	2018	128
Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre Ross W. Paterson, Michael S. Zandi, Richard Armstrong, Journal of Neurology Neurosurgery & Psychiatry	2013	126
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging Thomas D. Parker, Catherine F. Slattery, Jiaying Zhang, Human Brain Mapping	2018	119

Page 1